Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug...

Quince Therapeutics, previously Cortexyme, is a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases. Cortexyme acquired...

Siege Pharmaceuticals is developing new cancer drugs based on a naturally-occurring molecule that starves cancer cells to death.

NVasc, Inc. is an early-stage ophthalmology company focused on the treatment of ischemic eye diseases, such as age-related macular...

The world’s first COVID-19 testing device using RT-PCR, the gold standard of testing, to provide high accuracy results in...

Pinpoint Therapeutics is developing novel cancer treatment options aimed to specifically inhibit autophagy, a key cell survival and treatment...

Actuate Therapeutics is a clinical stage therapeutics company focusing on the treatment of high impact cancers and inflammatory diseases.

Linnaeus Therapeutics is a clinical-stage biotech company engaged in the identification and development of small molecule agents that modulate...